RASU B.
SHRESTHA

Rasu B. Shrestha, MD, MBA, is Enterprise Executive Vice President & Chief Innovation and Commercialization Officer for Advocate Health, one of the largest non-profit and leading academic health systems in the United States. As a member of the executive leadership team, Dr. Shrestha is responsible for Advocate Health’s enterprise innovation portfolio, including strategic industry partnerships, and Advocate Health’s strategic investment fund. In addition, he spearheads a renewed focus on commercialization, launching new healthcare inventions, discoveries and ideas to benefit our patients and the communities Advocate Health serves, and beyond.

Dr. Shrestha has nearly 30 years of industry experience as a transformative physician leader experienced in delivering results across strategy, innovation, health information technology, marketing, communications, strategic investments and commercialization. He joined Advocate Health, as part of Atrium Health, in January 2019 as EVP and Chief Strategy and Transformation Officer, leading the strategic transformation of the organization and was charged with the creation and implementation of IMPACT 2025, a bold multi-year enterprise strategic plan for the growing health system that includes key priorities such as operational excellence & path to value, environmental sustainability, innovations & partnerships, and growth, integrated scale & influence.

Dr. Shrestha was previously with UPMC, where he led the payor-provider organization’s innovation and strategy, and built the industry’s largest and most successful innovation, commercialization and venture capital engine. In addition to leading innovation at UPMC, Dr. Shrestha also served as executive vice president of UPMC Enterprises.

Dr. Shrestha is a respected thought leader and visionary with a strong track record of growth and impact, and a strong champion of a culture of growth and transformation.